Device Structural Heart

Prodigy

Payments companies reported to CMS as associated with Prodigy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$63Kassociated payments (2023-2025)
510clinicians with associated payments
2companies reporting

By year

2023 $20K
2024 $28K
2025 $16K

Payments reported as associated with Prodigy, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pain Medicine (Physical Medicine & Rehabilitation) $14K
Interventional Pain Medicine $13K
Pain Medicine (Anesthesiology) $11K
Family Medicine $5,893
Neurological Surgery $3,846
Physical Medicine & Rehabilitation $3,135

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Prodigy

These are the largest totals companies reported as associated with Prodigy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Pavli Demian Somerset, NJ Pain Medicine (Physical Medicine & Rehabilitation) $6,341.26
Kevin Soden Charlotte, NC Family Medicine $5,000.00
Ryan Nobles Mt Pleasant, SC Interventional Pain Medicine $4,150.00
Denis Patterson Reno, NV Pain Medicine (Physical Medicine & Rehabilitation) $4,090.00
Alan Torrey Vicksburg, MS Pain Medicine (Anesthesiology) $3,727.00
Sachin Narain Gilbert, AZ Interventional Pain Medicine $2,500.00
Steven Falowski Fountain Hill, PA Neurological Surgery $2,300.00
Richard Stayner Edina, MN Pain Medicine (Anesthesiology) $1,700.00
Youssef Josephson West Deptford, NJ Interventional Pain Medicine $1,470.00
Jonathan Silverman Dayton, OH Pain Medicine (Physical Medicine & Rehabilitation) $1,352.68

Prescribed Prodigy?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.